Zoetis raised its annual profit and revenue forecasts on Monday on strong demand for its medicines and vaccines for animals.
Zoetis saw notable growth in both companion animal and livestock segments.
Shares in Zoetis (NYSE:ZTS) edged higher in premarket US trading on Monday after the drugmaker reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback